1. Home
  2. UTF vs TARS Comparison

UTF vs TARS Comparison

Compare UTF & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cohen & Steers Infrastructure Fund Inc

UTF

Cohen & Steers Infrastructure Fund Inc

HOLD

Current Price

$28.00

Market Cap

3.1B

Sector

Finance

ML Signal

HOLD

Logo Tarsus Pharmaceuticals Inc.

TARS

Tarsus Pharmaceuticals Inc.

HOLD

Current Price

$58.46

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UTF
TARS
Founded
N/A
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.7B
IPO Year
2004
2020

Fundamental Metrics

Financial Performance
Metric
UTF
TARS
Price
$28.00
$58.46
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$89.00
AVG Volume (30 Days)
241.9K
1.4M
Earning Date
01-01-0001
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
48.21
EPS
N/A
N/A
Revenue
N/A
$451,360,000.00
Revenue This Year
N/A
$56.43
Revenue Next Year
N/A
$30.19
P/E Ratio
N/A
N/A
Revenue Growth
N/A
146.71
52 Week Low
$23.42
$38.51
52 Week High
$28.11
$85.25

Technical Indicators

Market Signals
Indicator
UTF
TARS
Relative Strength Index (RSI) 62.65 45.13
Support Level $26.54 $56.05
Resistance Level $28.11 $67.14
Average True Range (ATR) 0.29 3.54
MACD 0.00 -0.35
Stochastic Oscillator 82.89 23.72

Price Performance

Historical Comparison
UTF
TARS

About UTF Cohen & Steers Infrastructure Fund Inc

Cohen & Steers Infrastructure Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is total return with an emphasis on income. Under normal market conditions, the fund invests the majority of its managed assets in securities issued by infrastructure companies, which consist of utilities, pipelines, toll roads, airports, railroads, ports, telecommunications companies, and other infrastructure companies.

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.

Share on Social Networks: